Ohcanbohtosat - Tim Bancroft

Evaluation of adverse clinical outcomes in patients with inflammatory bowel disease receiving different sequences of first- and second-line biologic treatments: findings from ROTAR... Dahkki Noa Krugliak Cleveland, Sabyasachi Ghosh, Benjamin Chastek, Tim Bancroft, Ninfa Candela, Tao Fan, Kandavadivu Umashankar, David T. Rubin

Viečča ollesdeavstta

Gaps in hepatocellular carcinoma surveillance among insured patients with hepatitis B infection without cirrhosis in the United States Dahkki Mindie H. Nguyen, Lewis R. Roberts, Nicole M. Engel‐Nitz, Tim Bancroft, A. Burak Ozbay, Amit G. Singal

Viečča ollesdeavstta

Relative vaccine effectiveness of MF59-adjuvanted vs high-dose trivalent inactivated influenza vaccines for prevention of test-confirmed influenza hospitalizations during the 2017–... Dahkki Ian McGovern, Benjamin Chastek, Tim Bancroft, Noah Webb, Mahrukh Imran, Stephen I. Pelton, Mendel D.M. Haag

Viečča ollesdeavstta

Comparable effectiveness of MF59®-adjuvanted and high-dose quadrivalent inactivated influenza vaccines for prevention of test-confirmed influenza during the 2022-2023 influenza sea... Dahkki Mahrukh Imran, Benjamin Chastek, Tim Bancroft, Noah Webb, Stephen I. Pelton, Mendel D.M. Haag, Ian McGovern

Viečča ollesdeavstta

Real-world use of inotuzumab ozogamicin is associated with lower health care costs than blinatumomab in patients with acute lymphoblastic leukemia in the first relapsed/refractory... Dahkki Alexander Russell-Smith, Louise Murphy, Amy Nguyen, Cori Blauer-Peterson, Marilou Terpenning, Feng Cao, Shiqiang Li, Tim Bancroft, Noah Webb, Stephanie Dorman, Richa Shah

Health outcomes and costs in patients prescribed anticholinergic medications for overactive bladder Dahkki Holly E Richter, Benjamin Chastek, Adam Carrera, Christina Steiger, Daniel Snyder, Laleh Abedinzadeh, Tim Bancroft, Jeffrey Nesheim, Roger R Dmochowski, Adonis K Hijaz, Jeffrey Frankel